- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03840928
PatientSpot Formerly Known as ArthritisPower (GHLF)
Study Overview
Status
Conditions
- Heart Failure
- Stroke
- Epilepsy
- Multiple Sclerosis
- Obesity
- Diabetes
- Chronic Obstructive Pulmonary Disease
- Osteoarthritis
- Rheumatoid Arthritis
- Parkinson Disease
- Peripheral Arterial Disease
- Inflammatory Bowel Diseases
- Amyotrophic Lateral Sclerosis
- Psoriasis
- Asthma
- Muscular Dystrophy
- Fibromyalgia
- Alzheimer Disease
- Lung Cancer
- Sleep Apnea
- Eczema
- Crohn Disease
- Brain Tumor
- Headache
- Osteoporosis
- Cystic Fibrosis
- Meningitis
- Myositis
- Spinal Cord Injuries
- Ataxia
- Dermatomyositis
- Polymyositis
- Neurocutaneous Syndromes
- Chronic Inflammation
- Congenital Heart Disease
- Giant Cell Arteritis
- Polymyalgia Rheumatica
- Juvenile Idiopathic Arthritis
- Psoriatic Arthritis
- Tension-Type Headache
- Alopecia
- Gout
- Unstable Angina
- Chronic Liver Disease
- Cerebral Aneurysm
- Guillain-Barre Syndrome
- Head Injury
- Ankylosing Spondylitis
- Cluster Headache
- Lupus Erythematosus
- High Blood Pressure
- Hydrocephalus
- Lumbar Disc Disease
- Arrythmia
- Bell Palsy
- Scleroderma
- Axial Spondyloarthritis
- Valve Heart Disease
- Heart Attack
- Temporal Arteritis
- Relapsing Polychondritis
- Undifferentiated Connective Tissue Disease
- Diffuse Idiopathic Skeletal Hyperostosis
- Wegener
Detailed Description
Patient Power is a patient research network and database (registry) to collect prospective information about demographics, self-reported diagnoses and medications, and willingness to participate in research from participants with rheumatoid arthritis (RA), spondyloarthritis (SpA), other musculoskeletal conditions, chronic neurological conditions like migraine, chronic pulmonary conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, autoimmune dermatological conditions such as psoriasis, and other chronic inflammatory or immune-mediated conditions. In addition, since patients with chronic conditions often have other co-morbidities like cardiovascular health and obesity-related metabolic disorders, these conditions will also be included. Participants will provide information from their smartphones or personal computers. The information will be used by researchers and clinicians to help patients and their providers make better, more informed decisions about treatment of chronic conditions.
We have established a governance structure with highly engaged patients and stakeholders who will serve on a Patient Governor Group (PGG) and Research Advisory Board (RAB) to ensure Patient Power participant privacy and transparency about research activities. Online tools and a mobile application at me securely capture patient data. The software tools built include real-time connection to the adaptive version of NIH Patient Reported Outcomes Measurement Information System (PROMIS) instruments capturing patient reported data that minimizes participant burden and allows participants to immediately view their scores if they choose. The Patient Power App runs on both web browsers and smartphones with data stored in the Amazon Web Services (AWS) cloud, not on a participant's smartphone or browser. The App has four key design pillars: (1) Patient engagement, community integration and education by incorporating GHLF bloggers and chronic disease news and social media engagement to the app for education, support and research findings to be shared directly and immediately with those living with registry-eligible chronic conditions; (2) Personal longitudinal health and medication tracking by providing participants' access to their actively contributed patient reported outcome (PRO) and other health-related data (e.g. current and past medications). We will use messaging to encourage participants to regularly update their information, including medication information. For example, we may remind participants to contribute their medication information with the following message: "You don't have any active medications. You can record your medications in Patient Power. By adding your active medications, you will be able to see how your symptoms have changed since starting a new medication. Click here to start entering medications". (3) Health care decision making by allowing App users to share health tracking reports at their discretion with their providers or caregivers; and (4) Research opportunities by providing a platform where an array of new research opportunities can be browsed by participants to combat chronic diseases. The combination of solid governance structure with well-developed policies and procedures, engaged patient community, collaborative relationships with many research partners and our innovatively convenient and mobile approach to data collection make Patient Power a unique and powerful patient-led initiative in chronic disease research.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Laura Stradford, MPH
- Phone Number: 210 (845) 348 0400
- Email: lstradford@ghlf.org
Study Contact Backup
- Name: Shilpa Venkatachalam, PhD
- Phone Number: 110 (845) 348 0400
- Email: bnowell@ghlf.org
Study Locations
-
-
New York
-
Upper Nyack, New York, United States, 10960
- Recruiting
- Global Healthy Living Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Self-report that a physician has given a diagnosis of a chronic condition listed in the registry.
- The Registry is only intended at this time for residents of the United States and United States territories and Canada who are nineteen (19) years or older (for Puerto Rico residents, you must be 21 years or older to participate).
Exclusion Criteria
• Under 19 years old
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Lupus
|
|
Osteoporosis
|
|
Ankylosing Spondylitis
|
|
Fibromyalgia
|
|
Gout
|
|
Crohn's-related Arthritis
|
|
Juvenile Idiopathic Arthritis
|
|
Myositis
|
|
Osteoarthritis
|
|
Psoriasis
|
|
Psoriatic Arthritis
|
|
Rheumatoid Arthritis
|
|
Scleroderma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain Interference (PROMIS)
Time Frame: 7 days
|
7 days
|
|
Fatigue (PROMIS)
Time Frame: 7 days
|
7 days
|
|
Sleep Disturbance (PROMIS)
Time Frame: 7 days
|
7 days
|
|
Physical Function (PROMIS)
Time Frame: 7 days
|
7 days
|
|
RAPID-3 (MD-HAQ with visual analogue scale for pain and patient global measure for overall health)
Time Frame: 7 days
|
7 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Digestive System Diseases
- Ischemia
- Pathologic Processes
- Necrosis
- Myocardial Ischemia
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Skin Diseases
- Virus Diseases
- Infections
- Respiratory Tract Diseases
- Immune System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Lung Diseases
- Pain
- Neurologic Manifestations
- Neurocognitive Disorders
- Disease Attributes
- Disease
- Congenital Abnormalities
- Gastrointestinal Diseases
- Infant, Newborn, Diseases
- Genetic Diseases, Inborn
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Gastroenteritis
- Muscular Diseases
- Neuromuscular Diseases
- Stomatognathic Diseases
- Mouth Diseases
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- Peripheral Nervous System Diseases
- Intestinal Diseases
- Atherosclerosis
- DNA Virus Infections
- Pathological Conditions, Anatomical
- Vasculitis
- Skin Diseases, Genetic
- Skin Diseases, Vascular
- Trauma, Nervous System
- Spinal Cord Diseases
- TDP-43 Proteinopathies
- Proteostasis Deficiencies
- Skin Diseases, Papulosquamous
- Muscular Disorders, Atrophic
- Spinal Diseases
- Bone Diseases
- Dementia
- Tauopathies
- Cranial Nerve Diseases
- Herpesviridae Infections
- Pancreatic Diseases
- Spondylarthropathies
- Spondylarthritis
- Infarction
- Headache Disorders, Primary
- Headache Disorders
- Bone Diseases, Metabolic
- Cardiovascular Abnormalities
- Skin Abnormalities
- Abnormalities, Multiple
- Intracranial Arterial Diseases
- Chest Pain
- Psoriasis
- Aneurysm
- Vasculitis, Central Nervous System
- Angina Pectoris
- Hypotrichosis
- Hair Diseases
- Facial Nerve Diseases
- Bone Diseases, Infectious
- Ankylosis
- Polyradiculoneuropathy
- Polyneuropathies
- Trigeminal Autonomic Cephalalgias
- Cartilage Diseases
- Ectodermal Dysplasia
- Chronic Disease
- Spinal Osteophytosis
- Neuroinflammatory Diseases
- Post-Infectious Disorders
- Liver Diseases
- Myocardial Infarction
- Heart Diseases
- Multiple Sclerosis
- Sclerosis
- Hypertension
- Syndrome
- Arthritis
- Lung Diseases, Obstructive
- Pulmonary Disease, Chronic Obstructive
- Parkinson Disease
- Inflammation
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Inflammatory Bowel Diseases
- Wounds and Injuries
- Motor Neuron Disease
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophies
- Fibromyalgia
- Alzheimer Disease
- Crohn Disease
- Arthritis, Psoriatic
- Headache
- Osteoporosis
- Cystic Fibrosis
- Connective Tissue Diseases
- Heart Defects, Congenital
- Meningitis
- Myositis
- Spinal Cord Injuries
- Heart Valve Diseases
- Dermatomyositis
- Polymyalgia Rheumatica
- Giant Cell Arteritis
- Arteritis
- Arthritis, Juvenile
- Craniocerebral Trauma
- Angina, Unstable
- Tension-Type Headache
- Alopecia
- Spondylitis
- Spondylitis, Ankylosing
- Polymyositis
- Intracranial Aneurysm
- Guillain-Barre Syndrome
- Cluster Headache
- Hydrocephalus
- Bell Palsy
- Undifferentiated Connective Tissue Diseases
- Neurocutaneous Syndromes
- Polychondritis, Relapsing
- Hyperostosis
- Hyperostosis, Diffuse Idiopathic Skeletal
- Axial Spondyloarthritis
Other Study ID Numbers
- GlobalHealthyLivingF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States